Cargando…
Information to Improve Public Perceptions of the Food and Drug Administration (FDA’s) Tobacco Regulatory Role
While the Food and Drug Administration (FDA) has had regulatory authority over tobacco products since 2009, public awareness of this authority remains limited. This research examines several broad types of information about FDA tobacco regulatory mission that may improve the perceptions of FDA as a...
Autores principales: | Osman, Amira, Kowitt, Sarah D., Sheeran, Paschal, Jarman, Kristen L., Ranney, Leah M., Goldstein, Adam O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923795/ https://www.ncbi.nlm.nih.gov/pubmed/29661991 http://dx.doi.org/10.3390/ijerph15040753 |
Ejemplares similares
-
Awareness of and receptivity to FDA’s point-of-sale tobacco public education campaign
por: Dutra, Lauren M., et al.
Publicado: (2023) -
Public perceptions of the FDA’s marketing authorization of Vuse on Twitter/X
por: Lee, Sarah, et al.
Publicado: (2023) -
Tobacco Quit Intentions and Behaviors among Cigar Smokers in the United States in Response to COVID-19
por: Kowitt, Sarah D., et al.
Publicado: (2020) -
Physician Perceptions of the FDA’s Breakthrough Therapy Designation: An Update
por: Paquin, Ryan S, et al.
Publicado: (2022) -
The FDA’s Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
por: Marks, Peter
Publicado: (2019)